Oncogenesis 7 , 8 (2018)
Oct 18: Its been a charmed week for UCB, which on Wednesday announced its second straight approval, this one for bimekizumabnow Bimzelxfor adults with moderate-to-severe plaque psoriasis
In: UpToDate, Barnes PJ, Dieffenback P, eds
Regulatory Framework: Key FDA Guidance Documents for Nasal Sprays The foundation of nasal spray testing requirements in the United States is established by two primary FDA guidance documents, both from the Center for Drug Evaluation and Research (CDER): FDA CDER 2002 Nasal Spray and Inhalation Solution, Suspension and Spray Drug Products Chemistry, Manufacturing and Controls Documentation (CMC Guidance): Defines the CMC documentation requirements for new drug applications (NDAs) and abbreviated new drug applications (ANDAs) involving nasal spray and inhalation drug products
A little experimentation, combined with guidance from your provider, can go a long way toward finding what clicks for you
Additional information Active Ingredients Active Ingredients per mL Pack Sizes 50mL multi-dose vial
